Share

3M Company (MMM.NYSE) AI OPINIONS & ADVISOR ANALYSIS

Read and compare the 14 individual AI Advisor deep-dive reports, including their forecast paths, ratings, price targets, and reasoning.

Updated on 20 September 2026Deep analysis 20 September 2026

Publisher

Russlan Ramdowar

25 min readAudit All Past Forecasts

14 AI Advisor Reports

Select an advisor report.

SynthesizerCombines all advisor views

Synthesis of 14 independent opinions

Diversity of ModelsSame approach, varied models

Diversity of FrameworksDifferent investing styles

AI Researcher

Opus 5

Universal Investor AI

The Polymath Framework

Model rating

Neutral

5-Year Return Est.

+41.6%

Includes 1.27% annual net dividend contribution

1. Investment Thesis — Base Case

The central tension is that 3M has become an excellent restructuring while remaining an ordinary growth business, and the share price already pays for the former. Brown's operating-company conversion should deliver the 25% adjusted margin target by 2027, and roughly $4.5bn of annual buybacks will shrink the float three to five percent yearly [2][6]. But organic growth reverts toward two percent once self-help is spent, and a five percent long bond caps the multiple. Investors therefore earn earnings compounding and shareholder yield, not re-rating, with PFAS instalments quietly consuming a fifth of operating cash flow through 2036.

Adjusted EPS compounding from roughly $8.90 in 2026 toward $12.50-13.00 by 2031, mostly share-count driven.
At a 17x exit multiple, that implies a share price near $215-220 versus $166 today.
Cross-check: $115bn implied equity value on $5.5bn equals a 4.8% yield.

Historical prices and published forecast

Observed price
Published advisor forecast

Observed prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in USD.

View chart values

Historical prices and published forecast — published chart values
Series	Date	Value (USD)
Observed price	2021-09-18	152
Observed price	2021-10-11	148
Observed price	2021-10-28	150
Observed price	2021-11-09	152
Observed price	2021-11-14	152
Observed price	2021-12-02	144
Observed price	2021-12-13	146
Observed price	2022-01-05	150
Observed price	2022-01-11	150
Observed price	2022-01-29	137
Observed price	2022-02-09	136
Observed price	2022-03-04	122
Observed price	2022-03-10	120
Observed price	2022-03-22	125
Observed price	2022-04-20	126
Observed price	2022-04-25	121
Observed price	2022-05-07	125
Observed price	2022-05-24	122
Observed price	2022-06-05	123
Observed price	2022-06-28	109
Observed price	2022-07-15	108
Observed price	2022-07-27	117
Observed price	2022-08-13	126
Observed price	2022-08-25	119
Observed price	2022-08-30	104
Observed price	2022-09-23	94.5
Observed price	2022-10-10	91.5
Observed price	2022-10-22	98.5
Observed price	2022-10-27	103
Observed price	2022-11-14	109
Observed price	2022-11-25	108
Observed price	2022-12-18	102
Observed price	2022-12-24	100
Observed price	2023-01-10	108
Observed price	2023-02-03	96.8
Observed price	2023-02-14	94.0
Observed price	2023-02-20	92.0
Observed price	2023-03-15	86.3
Observed price	2023-03-21	84.9
Observed price	2023-04-13	88.2
Observed price	2023-04-19	88.2
Observed price	2023-05-12	84.1
Observed price	2023-05-29	79.6
Observed price	2023-06-10	85.2
Observed price	2023-06-16	85.7
Observed price	2023-07-03	82.6
Observed price	2023-07-14	86.2
Observed price	2023-07-26	92.2
Observed price	2023-08-18	83.4
Observed price	2023-09-04	89.1
Observed price	2023-09-10	87.3
Observed price	2023-10-03	74.7
Observed price	2023-10-15	74.1
Observed price	2023-11-01	77.4
Observed price	2023-11-07	77.1
Observed price	2023-11-30	84.2
Observed price	2023-12-06	86.5
Observed price	2023-12-29	90.6
Observed price	2024-01-10	91.0
Observed price	2024-01-27	80.2
Observed price	2024-02-02	79.8
Observed price	2024-02-25	76.8
Observed price	2024-03-02	76.9
Observed price	2024-03-19	88.0
Observed price	2024-04-17	91.1
Observed price	2024-04-23	93.0
Observed price	2024-04-28	92.2
Observed price	2024-05-16	102
Observed price	2024-05-27	98.7
Observed price	2024-06-20	102
Observed price	2024-07-07	100
Observed price	2024-07-18	104
Observed price	2024-07-24	103
Observed price	2024-08-16	127
Observed price	2024-08-22	130
Observed price	2024-09-14	134
Observed price	2024-09-26	139
Observed price	2024-10-07	135
Observed price	2024-10-19	133
Observed price	2024-10-25	127
Observed price	2024-11-17	129
Observed price	2024-11-28	132
Observed price	2024-12-16	129
Observed price	2025-01-08	131
Observed price	2025-01-14	137
Observed price	2025-01-31	152
Observed price	2025-02-17	147
Observed price	2025-03-01	149
Observed price	2025-03-18	152
Observed price	2025-04-05	137
Observed price	2025-04-22	130
Observed price	2025-05-03	138
Observed price	2025-05-09	144
Observed price	2025-05-15	152
Observed price	2025-06-19	145
Observed price	2025-06-30	152
Observed price	2025-07-18	157
Observed price	2025-07-23	151
Observed price	2025-08-04	149
Observed price	2025-08-21	158
Observed price	2025-09-08	154
Observed price	2025-09-13	157
Observed price	2025-10-12	150
Observed price	2025-10-24	167
Observed price	2025-11-04	163
Observed price	2025-11-22	169
Observed price	2025-11-28	172
Observed price	2025-12-21	161
Observed price	2026-01-13	169
Observed price	2026-01-19	158
Observed price	2026-01-30	155
Observed price	2026-02-11	173
Observed price	2026-02-22	166
Observed price	2026-03-17	145
Observed price	2026-03-29	143
Observed price	2026-04-15	151
Observed price	2026-04-21	146
Observed price	2026-05-03	142
Observed price	2026-05-20	151
Observed price	2026-06-12	159
Observed price	2026-06-24	167
Observed price	2026-07-11	158
Observed price	2026-07-17	160
Observed price	2026-08-09	182
Observed price	2026-08-15	182
Observed price	2026-09-07	168
Observed price	2026-09-13	163
Observed price	2026-09-23	170
Observed price	2026-09-25	170
Published advisor forecast	2026-09-18	166
Published advisor forecast	2026-12-18	171
Published advisor forecast	2027-03-18	167
Published advisor forecast	2027-06-18	172
Published advisor forecast	2027-09-18	176
Published advisor forecast	2027-12-18	181
Published advisor forecast	2028-03-18	176
Published advisor forecast	2028-06-18	181
Published advisor forecast	2028-09-18	185
Published advisor forecast	2028-12-18	190
Published advisor forecast	2029-03-18	194
Published advisor forecast	2029-06-18	196
Published advisor forecast	2029-09-18	200
Published advisor forecast	2029-12-18	204
Published advisor forecast	2030-03-18	200
Published advisor forecast	2030-06-18	204
Published advisor forecast	2030-09-18	208
Published advisor forecast	2030-12-18	212
Published advisor forecast	2031-03-18	214
Published advisor forecast	2031-06-18	216
Published advisor forecast	2031-09-18	221

2. Scenarios & Signals

Bull case

The bull case activates when litigation certainty and margin delivery arrive together. A global AFFF personal-injury settlement in the low single-digit billions removes the last unquantified liability, permitting the market to capitalise free cash flow rather than discount scenarios; simultaneously, 2027 adjusted margin clears 25% and GAAP charges finally recede, narrowing the ten-point reporting wedge. Buyback capacity then expands into a rising multiple, a genuinely reflexive loop. Shares approach 20x on $13 of earnings.

Bear case

The bear case begins when the pricing promise meets falling volumes. Persistent $100-plus Brent and a 4% funds rate tip industrial demand into contraction during 2027-28, so the $150-175m energy headwind is absorbed rather than passed through, backlog converts at compressed margin, and drops below $4bn. With book equity of only $4.70bn, an adverse AFFF bellwether then forces reserve building, buybacks pause, and the per-share engine stalls abruptly.

Current crowd narrative

The settled belief is that Bill Brown fixed 3M and PFAS is now a bill, not a threat. Sell-side anchors on the $8.80-8.95 adjusted guide and a roughly $180 target, treating 18.7x forward as cheap versus quality-industrial peers [3][19]. The anchoring bias: adjusted earnings are treated as the true earnings, and the 29.2x trailing GAAP multiple is dismissed as noise.

Alpha-gap assessment

Slightly overestimated rather than dramatically mispriced. The crowd capitalises adjusted earnings while ignoring that the roughly ten-point Q2 wedge between 15.1% GAAP and 24.9% adjusted operating margin has recurred every year since 2023, making it a cost of doing business, not a one-off [1]. Two-thirds of the re-rating from 2024 lows is already banked, and roughly half of 2026 is finite self-help worth about $450m [5]. Genuine quality, fully-paid price.

Convergence catalyst

The October 2026 Q3 print is the referendum: must swing sharply higher to reach the $4.7-4.9bn guide from $3.98bn TTM [4]. Confirmation would show in restructuring charges shrinking, narrowing the GAAP-adjusted wedge; the first observable repricing sign is GAAP EPS growth outpacing adjusted.

Paywalled preview begins: Macro-regime alignment

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Sentiment and regime

Greed and fear sentiment: 0.2
Expected volatility regime: moderate
Convergence-cycle position: momentum

Primary drivers

Primary drivers supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Holding Company Becomes Operating Compan	The decisive evidence is structural, not cyclical: Brown is collapsing a federated holding-company model into an integrated operator, consolidating factories, supply chains and back office, with adjusted operating margin expansion of 70-80bps guided for 2026 and management tracking above a 25% goal for 2027 [2][6]. Q2 2026 adjusted margin of 24.9% already validates direction [1]. Each 100bps on ~$25bn of revenue is roughly $250m of pre-tax income.	Not available	+18.0%
Buyback Flywheel Shrinks THE Float	Follow the cash, not the narrative: FY2025 repurchases of $4.81bn dwarfed $1.18bn of dividends, and TTM net buyback yield sits near 2.95% against an $87.5bn capitalisation [4][5]. With guided free cash flow of $4.7-4.9bn and a 528m share count, management can retire roughly 3-5% of equity annually while still funding the $0.78 quarterly dividend [9]. Per-share earnings therefore compound faster than revenue, and that mechanism persists as long as litigation instalments stay scheduled.	Not available	+14.0%
Innovation Engine Restarts Orders LEAD	Orders rose about 10% and backlog about 20% year over year in Q2 2026, with 92 new products launched, up 44%, against a plan exceeding 350 [4][5]. Leading indicators running ahead of reported revenue is precisely the corroboration the innovation-restart claim requires, and it is present. Management attributes roughly $450m of 2026 revenue to above-macro self-help, which converts directly into incremental contribution margin.	Not available	+10.0%
PFAS Becomes A Scheduled Annuity	The public-water-supplier settlement is court-approved and already in payment: $10.5-12.5bn total, charged at $10.3bn present value in 2023, disbursed 2024-2036 [10][11]. New Jersey settled at roughly $450m nominal over 25 years [12][14]. Converting an unbounded tail risk into roughly $1bn of annual, tax-deductible, budgeted outflow permits equity investors to discount cash flows rather than scenarios, which mechanically lifts the multiple applied to those flows.	Not available	+9.0%

Primary frictions

Primary frictions supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
FIVE Percent Discount RATE BOND Proxy P	The Fed lifted to 3.75%-4.00% on 16 September 2026 with median 2026-27 dots at 4.1%, and the 10-year yield closed near 4.998%. For a low-growth industrial valued largely on dividend and buyback yield, every rise in the risk-free rate compresses the multiple arithmetically. The roughly 4% drawdown from July's $173 high into September occurred on rates, not earnings, which demonstrates the sensitivity directly.	Not available	-14.0%
THE TEN Point GAAP Adjusted Wedge	The anomaly that governs valuation: Q2 2026 GAAP operating margin of 15.1% fell 290bps while adjusted margin of 24.9% rose 40bps [1]. Trailing GAAP EPS of $5.68 supports a 29.2x multiple; the $8.80-8.95 adjusted guide supports 18.7x [3]. Until restructuring and litigation charges genuinely run off rather than recur annually, sceptical investors capitalise the lower number, capping the re-rating.	Not available	-10.0%
Energy Shock Meets Pricing Promise	3M quantifies oil-related input-cost headwinds at $150-175m and promises a dollar-for-dollar pricing offset of roughly 1.5 points for 2026, near 2% in the second half [6][7]. With Brent at $103.87 and European TTF up 13.9% month to date, that offset is a plan, not a result. The headwind equals 60-70bps of margin on $25bn revenue, and price realisation historically fades as industrial volumes soften.	Not available	-8.0%
TWO Percent CORE Borrowed Growth	Strip the $450m of self-help from guided organic growth above 3.5% and the underlying franchise grows roughly two percent, consistent with 2015-2025 revenue that never durably exceeded the 2018 peak [2][5]. Self-help is finite: factory consolidation, attrition improvement and portfolio pruning are one-time levers. Once exhausted around 2028-29, the market re-anchors on GDP-like growth and applies an industrial-average multiple rather than a turnaround premium.	Not available	-7.0%

Tail opportunities

Tail opportunities supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Optics AND A Portfolio Break UP	Expanded Beam Optics is standardised by Microsoft Azure, evaluated by five other hyperscalers, and addresses a market approaching $2bn within two years, with capacity more than doubled since March 2026 [6][7]. If that scales alongside a decision to separate Safety & Industrial or Transportation, following the Solventum and Scott Safety templates, investors would apply a growth multiple to a structurally faster portfolio during 2028-30. It remains below fifty percent because $2bn addressable against $25bn revenue cannot re-rate the whole company on execution alone.	25.0%	+26.0%
Global AFFF Settlement CAPS THE TAIL	A negotiated global personal-injury resolution, which plaintiff counsel widely expect in 2026-27 once bellwether outcomes arrive, would remove the last unquantified PFAS variable [17]. With 15,264 MDL cases and speculative per-claim estimates of $75,000-$500,000, a multi-defendant allocation plausibly lands in the low single-digit billions for 3M, affordable against $4.7-4.9bn annual free cash flow [13][18]. Certainty, not size, drives the re-rating. Probability stays below half because Judge Gergel has no bellwether date set and claim counts keep rising.	40.0%	+18.0%

Tail risks

Tail risks supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Bellwether Verdict Reopens THE TAIL	The first personal-injury bellwether focuses on kidney cancer; an adverse nine-figure verdict with punitive damages during 2027-28 would reset plaintiff expectations, accelerate filings beyond the current 15,264, and force a far larger reserve than the market assumes [15][16][18]. With book equity of only $4.70bn and debt-to-equity near 2.75, a multi-billion incremental charge would pressure the credit profile and suspend the buyback that carries per-share growth. Below fifty percent because settlement pressure from the bench favours resolution over trial.	30.0%	-24.0%
Industrial Recession Breaks THE Price Offset	If the Fed's higher-for-longer stance plus a $100-plus Brent tax on industrial demand tips manufacturing into contraction during 2027-28, the pricing offset to the $150-175m energy headwind fails, backlog converts at lower margin, and organic growth turns negative [6][7]. Operating leverage reverses, free cash flow falls below $4bn, and buyback capacity shrinks precisely when the multiple compresses. Probability sits below half because US consumption remains resilient and August retail sales rose 1.2% month over month.	30.0%	-22.0%

Step-by-step forecast path

Universal Investor forecast path for prediction task predrqst_batch_task__xrefsubjtskconf_60d30405-03f4-59c3-a309-e4c990ab9fd2__sb7__20260920064920277661
Step	Forecast date	Step change	Projected value (USD)	Scenario rationale
1	December 18, 2026	+3.0%	170.87	October Q3 print tests whether free cash flow converges toward the $4.7-4.9bn guide. Modest beat plus year-end buyback support offsets a 5% ten-year yield, producing a contained recovery from September softness.
2	March 18, 2027	-2.0%	167.45	January guidance for 2027 lands conservatively as management embeds full-year energy costs and lapping self-help comparisons. Industrial order momentum decelerates from Q2 2026's 10% pace, prompting modest multiple compression.
3	June 18, 2027	+3.0%	172.47	Madison-Scott joint venture accretion and first-quarter margin evidence toward the 25% target reassure investors. Pricing realisation near 2% holds against moderating oil, restoring confidence in operating leverage.
4	September 18, 2027	+2.0%	175.92	Buyback cadence of roughly $1bn quarterly steadily reduces share count, lifting per-share earnings even as organic growth normalises toward three percent. Rate stabilisation removes the discount-rate headwind that dominated 2026.
5	December 18, 2027	+3.0%	181.20	Full-year 2027 delivery of the 25% adjusted operating margin validates the operating-company thesis. Narrowing GAAP-to-adjusted wedge begins attracting cash-flow-based investors who previously discounted the restructuring story.
6	March 18, 2028	-3.0%	175.76	AFFF bellwether scheduling news and slowing industrial capital spending weigh simultaneously. Investors mark down the litigation tail ahead of trial, while 2028 guidance reveals self-help levers largely exhausted.
7	June 18, 2028	+3.0%	181.04	Probable progress toward a negotiated personal-injury framework reduces tail uncertainty. Expanded Beam Optics volumes with additional hyperscalers add a small but narratively powerful growth vector to a slow-growth portfolio.
8	September 18, 2028	+2.0%	184.66	Cumulative float reduction approaching twelve percent since 2026 delivers per-share growth despite two-percent organic revenue. Dividend raises resume at mid-single-digit pace, supporting the yield-oriented shareholder base.
9	December 18, 2028	+3.0%	190.20	Easing policy rates as inflation normalises lower the discount applied to a stable cash generator. Free cash flow above $5bn funds both instalment obligations and repurchases without balance-sheet strain.
10	March 18, 2029	+2.0%	194.00	Portfolio review yields further divestitures of low-return lines, improving mix. Investors reward disciplined capital allocation, though decelerating top-line growth prevents any material multiple expansion beyond industrial averages.
11	June 18, 2029	+1.0%	195.94	Growth reverts toward underlying GDP-like rates as the turnaround premium fades. Earnings still advance on buybacks, but the market applies a mature-industrial multiple, limiting price appreciation this quarter.
12	September 18, 2029	+2.0%	199.86	Data-centre optics and advanced materials reach meaningful revenue scale, offsetting mature consumer and transportation lines. Incremental mix improvement supports margins above 25% and steady free-cash-flow conversion.
13	December 18, 2029	+2.0%	203.86	Year-end results confirm durable mid-twenties margins and roughly $5.5bn free cash flow. PFAS instalments remain a predictable roughly $1bn annual outflow, no longer a source of valuation discount.
14	March 18, 2030	-2.0%	199.78	A cyclical inventory correction across industrial distribution channels trims volumes. With little organic growth cushion remaining, modest revenue disappointment translates directly into a share-price setback.
15	June 18, 2030	+2.0%	203.78	Recovery in manufacturing orders plus continued repurchases restore the per-share trajectory. Book equity rebuilding after litigation charges improves credit metrics and lowers the cost of incremental debt-funded buybacks.
16	September 18, 2030	+2.0%	207.85	Steady-state compounding dominates: two-percent organic growth, modest margin gains and four-percent float reduction combine into high-single-digit earnings-per-share growth at a stable seventeen-times multiple.
17	December 18, 2030	+2.0%	212.01	Management sets a post-2030 financial framework emphasising cash returns over acquisitions. Predictability appeals to income investors, sustaining the valuation but capping upside absent a genuine growth re-rating.
18	March 18, 2031	+1.0%	214.13	Remaining PFAS instalments through 2036 continue absorbing roughly a fifth of operating cash flow, constraining reinvestment. Share performance tracks earnings growth closely with no multiple change.
19	June 18, 2031	+1.0%	216.27	Competitive pressure in abrasives and adhesives from lower-cost Asian producers limits pricing power. Margin gains plateau near the structural ceiling, leaving buybacks as the dominant per-share lever.
20	September 18, 2031	+2.0%	220.60	Horizon-end valuation near seventeen times roughly $13 of adjusted earnings. The turnaround is complete and fully priced; total return now depends on dividend plus buyback yield rather than re-rating.

Advisor and configuration

Advisor: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release
Persona: Universal Investor
Archetype: The Polymath
Model: 2026-07-24 release
Provider: Anthropic
Mode: RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity
Task configuration: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release__equity__json__extnd_invest_thesis_4q_alphassym__ts_num_desc__h5y_s3m__var1__researcher__standard_creativity_high_thinking__batch
Forecast horizon: 5 year
Forecast steps: 20 steps of 3 month
Assembly type: Balanced Assembly
Assembly name: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release RESEARCHER Forecast Assembly
Input format: inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
Output format: Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)

Read the complete Universal Investor advisor methodology

Configuration components

aiassmprmtcmpnt_b995bbe2-6a15-55be-a576-525904f696e8
aiassmprmtcmpnt_c55d1851-d218-5d30-b83b-54bbda31e2ee
aiassmprmtcmpnt_930157b1-05d7-5699-bf0a-738645ee42fd
aiassmprmtcmpnt_3c0c459a-0d4a-50ca-87df-c172ec5618aa
aiassmprmtcmpnt_8115cc2a-d418-54b1-a616-49dfa91195f4

Research sources

[1]3M CO - Form 8-K - FY2026sec.gov
[2]3M Reports Second-Quarter 2026 Results; Increases Full-Year Guidance - Jul 21, 2026news.3m.com
[3]3M Q2 2026 earnings beat, full-year guidance raisedfinance.yahoo.com
[4]Earnings call transcript: 3M beats Q2 2026 estimates and lifts outlook By Investing.cominvesting.com
[5]3M Co (MMM) Q2 2026 Earnings Call Highlights: Strong Growth and Raised Guidancefinance.yahoo.com
[6]3M CEO Touts Data-Center Push, Margin Gains and Progress Toward 2027 Targets - NewsBreaknewsbreak.com
[7]3M lifts guidance on Q2 profits, eyes AI data center growth - TheStreetthestreet.com
[8]3M Partners with Bain Capital to Acquire Madison Fire & Rescuefinance.yahoo.com
[9]3M News Center - Press Releasesnews.3m.com
[10]3M CO - Form 10-Q - FY2024sec.gov
[11]3M Firefighting Foam Settlement (2026 Update) - $12.5Bharmreport.com
[12]3M PFAS Water Contamination Settlement Results in $450M Payout to New Jersey - AboutLawsuits.comaboutlawsuits.com
[13]PFAS Lawsuit: $12.5 Billion 3M PFAS Contamination Settlementconsumernotice.org
[14]3M Resolves PFAS-Related Claims with the State of New Jersey :: 3M Company (MMM)investors.3m.com
[15]Afff Lawsuit - Complete Definitive Guide (2026)masstortinfo.com
[16]AFFF Lawsuit | Firefighting Foam August 2026 Settlement Updatelawsuit-information-center.com
[17]AFFF PFAS Lawsuit | MDL-2873 | September 2026 | MDL Updatemdlupdate.com
[18]AFFF Lawsuits: September 2026 Updates & Settlement Amountsdrugwatch.com
[19]3M Beats Q2 Estimates, Raises Guidance; Execs Cash Outbasisreport.com

Back to advisor navigation

End of the paywalled preview

The excerpt from Macro-regime alignment to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Other AI Advisor reports — limited previews

Superintelligence — RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity

Gemini 3.8 Flash

Limited structural preview, provided as simplified HTML. The complete report contains substantially more research: its investment thesis; bull and bear scenarios; macro-regime analysis; drivers, risks and opportunities; quarterly forecast tables and rationale; references and published configuration. Those findings and datasets are not included here. Sign in with the required subscription to open this advisor's full report.